Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Provectus Biopharms (OP:PVCT)

0.0473 -0.0001 (-0.21%)
Streaming Delayed Price Updated: 3:41 PM EST, Feb 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,218
Open 0.0474
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0474
Today's Range 0.0472 - 0.0474
52wk Range 0.0380 - 0.1130
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Noninvasive Eye Infection Treatment Shows Promise
(NewsUSA) - Those who suffer from eye infections that threaten a person’s vision have a new treatment option that is noninvasive and counters the problem of antibiotic resistance, based on recent... 
Via NewsUSA
News headline image
PVCT Stock Earnings: Provectus Reported Results for Q2 2024 ↗
Provectus just reported results for the second quarter of 2024. 
Via InvestorPlace

Performance

YTD
-25.9%
-25.9%
1 Month
-11.9%
-11.9%
3 Month
-22.5%
-22.5%
6 Month
-46.4%
-46.4%
1 Year
-54.9%
-54.9%

More News

Read More
News headline image
PVCT Stock Earnings: Provectus Reported Results for Q1 2024 ↗
Via InvestorPlace
News headline image
PVCT Stock Earnings: Provectus Reported Results for Q4 2023 ↗
Via InvestorPlace
News headline image
Trading Volume In The OTCQB Venture Market Picks Up in December – A Summary Of OTC Market Group's Most Active List In December ↗
Via Benzinga
News headline image
Provectus Biopharmaceuticals Announces Decision to Not Undertake Reverse Split of Outstanding and Authorized Equities in 2022; Expects to Seek Same Stockholder Approval Again in 2023
From Provectus Biopharmaceuticals Inc.
Via GlobeNewswire
News headline image
Provectus Biopharmaceuticals Announces New Data from Combination Therapy Trial of Small Molecule Cancer Immunotherapy PV-10® and Keytruda® for First-Line Stage III Melanoma at Melanoma Bridge 2022
From Provectus Biopharmaceuticals Inc.
Via GlobeNewswire
News headline image
Provectus Biopharmaceuticals Announces Acceptance of Small Molecule Cancer Immunotherapy PV-10® Stage III Melanoma Abstract at Melanoma Bridge 2022
From Provectus Biopharmaceuticals Inc.
Via GlobeNewswire
News headline image
Provectus Biopharmaceuticals Announces World Health Organization Selection of “Rose Bengal Sodium” as International Nonproprietary Name for Active Pharmaceutical Ingredient
From Provectus Biopharmaceuticals Inc.
Via GlobeNewswire
News headline image
Provectus Biopharmaceuticals Expands Research Collaboration with The Rockefeller University to Investigate Clinical-Stage Immuno-Dermatology Agent PH-10 for Skin Inflammation
From Provectus Biopharmaceuticals Inc.
Via GlobeNewswire
News headline image
Provectus Biopharmaceuticals Establishes Research Collaboration with University of Texas Medical Branch at Galveston to Investigate Pharmaceutical-Grade Small Molecule Immunotherapy Rose Bengal for Wound Healing
From Provectus Biopharmaceuticals Inc.
Via GlobeNewswire

Frequently Asked Questions

Is Provectus Biopharms publicly traded?
Yes, Provectus Biopharms is publicly traded.
What exchange does Provectus Biopharms trade on?
Provectus Biopharms trades on the OTC Traded
What is the ticker symbol for Provectus Biopharms?
The ticker symbol for Provectus Biopharms is PVCT on the OTC Traded
What is the current price of Provectus Biopharms?
The current price of Provectus Biopharms is 0.0473
When was Provectus Biopharms last traded?
The last trade of Provectus Biopharms was at 02/17/26 03:41 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.